| 前收市價 | 31.05 |
| 開市 | 30.80 |
| 買盤 | 32.09 x 13000 |
| 賣出價 | 32.31 x 12700 |
| 今日波幅 | 30.80 - 30.80 |
| 52 週波幅 | 29.45 - 44.20 |
| 成交量 | |
| 平均成交量 | 158 |
| 市值 | 16.323B |
| Beta 值 (5 年，每月) | 0.57 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.07 |
| 業績公佈日 | 2024年7月25日 - 2024年7月29日 |
| 遠期股息及收益率 | 1.08 (3.48%) |
| 除息日 | 2024年5月31日 |
| 1 年預測目標價 | 94.13 |
ReutersCarlyle in talks to buy Baxter's kidney care unit, source says
Shares of the Deerfield, Illinois-based firm rose more than 4%. Medical device maker Baxter said in March it had been in discussions with select private equity investors to explore a potential sale of the kidney care unit more than a year after it announced plans to separate the unit amid supply-chain challenges and weak demand for dialysis operations. Baxter declined to comment while Carlyle did not immediately respond to a Reuters request for comment.
ZacksReasons to Retain Baxter International (BAX) in Your Portfolio Now
Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, boosts confidence. However, pandemic-related disruption continues to hurt sales.
Insider MonkeyDid Baxter International Inc. (BAX) Beat the Market in Q1?
We recently compiled a list of the 10 Best Healthcare Stocks to Buy Under $50. In this article, we are going to take a look at where Baxter International Inc. (NYSE:BAX) stands against the other healthcare stocks under $50. If interested, you can also read our recent article on the 10 Best Healthcare Stocks To […]
